|
US1960170A
(en)
*
|
|
1934-05-22 |
|
Cc - phenylethyl - n - |
|
US2119701A
(en)
|
1934-06-29 |
1938-06-07 |
Winthrop Chem Co Inc |
Alkoxyalkyl mercury nitrogen compounds
|
|
US2673205A
(en)
*
|
1951-02-13 |
1954-03-23 |
Ciba Pharm Prod Inc |
3-disubstituted dioxopiperidines and the manufacture thereof
|
|
DE946804C
(de)
|
1952-02-28 |
1956-08-09 |
Emanuel Merck Ohg |
Verfahren zur Herstellung von schwefelhaltigen Abkoemmlingen der Barbitursaeure
|
|
DE1103339B
(de)
|
1959-02-04 |
1961-03-30 |
Chemische Werke Radebeul Veb |
Verfahren zur Herstellung von in 5-Stellung crotylierten, basisch substituierten Barbitursaeure-derivaten
|
|
DE1100639B
(de)
|
1959-03-24 |
1961-03-02 |
Chemische Werke Radebeul Veb |
Verfahren zur Herstellung von basisch substituierten Barbitursaeure-derivaten
|
|
GB966098A
(en)
|
1959-11-23 |
1964-08-06 |
Sapos Sa |
Barbiturate derivatives
|
|
US3930006A
(en)
*
|
1963-04-30 |
1975-12-30 |
Aspro Nicholas Ltd |
Antiparkinsonism compositions and method
|
|
US4046894A
(en)
*
|
1968-08-05 |
1977-09-06 |
Bristol-Myers Company |
Certain barbituric acid derivatives used as anticonvulsant agents
|
|
US3679683A
(en)
|
1970-05-11 |
1972-07-25 |
Exxon Research Engineering Co |
Barbiturate 3-n-methylene phosphates
|
|
US3711607A
(en)
*
|
1971-03-17 |
1973-01-16 |
Kendall & Co |
N,n -dihalomethyl phenobarbital for the treatment of convulsions
|
|
US3919427A
(en)
*
|
1972-06-02 |
1975-11-11 |
Kendall & Co |
Therapeutic compositions containing 1-methyl-3-alkoxymethyl-5,5-disubstituted barbituric acid compounds
|
|
US3904627A
(en)
*
|
1972-06-02 |
1975-09-09 |
Kendall & Co |
1-methyl-3-alkoxymethyl-5,5-disubstituted barbituric acid compounds
|
|
US3900475A
(en)
*
|
1972-06-26 |
1975-08-19 |
Kendall & Co |
Certain phenobarbital salts
|
|
US3948896A
(en)
*
|
1973-02-28 |
1976-04-06 |
The Kendall Company |
N-mono(alkoxymethyl) phenobarbitals, process therefor and therapeutic composition and method containing same
|
|
US4060528A
(en)
*
|
1975-10-08 |
1977-11-29 |
Janssen Pharmaceutica N.V. |
Aroyl-substituted phenylmalonic acid derivatives
|
|
US4029662A
(en)
*
|
1976-04-30 |
1977-06-14 |
Bristol-Myers Company |
Method of making barbituric acid derivatives
|
|
DE2622981A1
(de)
|
1976-05-21 |
1977-12-08 |
Unisearch Ltd |
Verfahren zur herstellung von halogenalkylierten verbindungen
|
|
US4260769A
(en)
|
1977-04-22 |
1981-04-07 |
Interx Research Corporation |
5,5-Diphenylhydantoins
|
|
EP0103233B1
(en)
*
|
1982-08-31 |
1987-11-25 |
Daikin Kogyo Co., Ltd. |
A method to trap the enolate ion of the malonic acid or its derivatives
|
|
IL69722A
(en)
|
1983-09-14 |
1986-09-30 |
Taro Pharma Ind |
Oxopyrimidine derivatives and pharmaceutical compositions containing them
|
|
US4631294A
(en)
*
|
1985-07-05 |
1986-12-23 |
University E.M., Inc. |
Treatment of cerebral ischemia with dichloroacetate
|
|
IT1196500B
(it)
*
|
1986-07-16 |
1988-11-16 |
Eniricerche Spa |
Derivati dell'acido malonico e metodi per la loro sintesi
|
|
HU196775B
(en)
*
|
1986-08-05 |
1989-01-30 |
Richter Gedeon Vegyeszet |
Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
|
|
US4833148A
(en)
*
|
1987-04-09 |
1989-05-23 |
Washington University |
Method of using alkenyl- or alkynyl-substituted thiobarbiturates to reduce neurotoxic injury
|
|
US5474990A
(en)
*
|
1989-10-20 |
1995-12-12 |
Olney; John W. |
Barbiturates as safening agents in conjunction with NMDA antagonists
|
|
DE4028040A1
(de)
|
1990-09-05 |
1992-03-12 |
Chemie Linz Deutschland |
Verfahren zur n-alkylierung von harnstoffen
|
|
US5456851A
(en)
|
1994-04-07 |
1995-10-10 |
Johnson & Johnson Consumer Products, Inc. |
Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole
|
|
DE4433764A1
(de)
|
1994-09-22 |
1996-03-28 |
Asta Medica Ag |
Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
|
|
DE19504623A1
(de)
|
1995-02-13 |
1996-08-14 |
Bayer Ag |
Verfahren zur Herstellung von N-substituierten cyclischen Imiden
|
|
RU2147584C1
(ru)
*
|
1995-10-27 |
2000-04-20 |
Американ Цианамид Компани |
Способ получения дигалоидазолопиримидинов и способ получения дигидроксиазолопиримидинов
|
|
KR100194535B1
(ko)
*
|
1995-12-27 |
1999-06-15 |
우종일 |
아릴 벤조일 우레아 유도체 및 이를 함유하는 농약조성물
|
|
EP0949259B1
(en)
*
|
1996-12-26 |
2001-06-20 |
Nikken Chemicals Company, Limited |
N-hydroxyurea derivatives and medicinal compositions containing the same
|
|
US5750766A
(en)
*
|
1997-03-18 |
1998-05-12 |
American Cyanamid Company |
Process for the preparation of arylmalonates
|
|
US5756815A
(en)
*
|
1997-03-18 |
1998-05-26 |
American Cyanamid Company |
Process for the preparation arylamalonates
|
|
US6093820A
(en)
*
|
1997-10-02 |
2000-07-25 |
Taro Pharmaceutical Industries Ltd. |
Method and reagents for N-alkylating ureides
|
|
CA2317008C
(en)
|
1997-12-31 |
2009-01-20 |
The University Of Kansas |
Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof
|
|
DE69906960T2
(de)
*
|
1998-05-08 |
2004-01-29 |
Smithkline Beecham Plc |
Phenylurea und phenylthio urea derivate
|
|
IL139884A0
(en)
|
1998-05-26 |
2002-02-10 |
Natural Drug Sciences Llc |
N-substituted derivatives of 5-oximinobarbituric acid
|
|
US6156925A
(en)
*
|
1998-09-25 |
2000-12-05 |
American Cyanamid Company |
Process for the preparation of halogenated phenylmaloates
|
|
US7214658B2
(en)
*
|
2004-07-06 |
2007-05-08 |
Tact Ip, Llc |
Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection
|
|
US6262067B1
(en)
*
|
1999-06-22 |
2001-07-17 |
Pfizer Inc. |
Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
|
|
US6281207B1
(en)
|
1999-09-15 |
2001-08-28 |
Reed Richter |
Treatment of movement disorders by administration of mirtazapine
|
|
EE200200274A
(et)
*
|
1999-12-01 |
2003-06-16 |
Ucb, S.A. |
Pürrolidiinatseetamiidi derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud kesknärvisüsteemi häirete ravimiseks, ja farmatseutiline kompositsioon
|
|
WO2001052823A2
(en)
*
|
2000-01-20 |
2001-07-26 |
Noven Pharmaceuticals, Inc. |
Compositions to effect the release profile in the transdermal administration of drugs
|
|
CA2306170A1
(en)
|
2000-04-18 |
2001-10-18 |
Kenneth Curry |
Novel amino, carboxy derivatives of barbituric acid
|
|
AU2001280778B2
(en)
*
|
2000-07-26 |
2004-09-02 |
Taro Pharmaceutical Industries Ltd. |
Non-sedating barbiturate compounds as neuroprotective agents
|
|
US6939873B2
(en)
*
|
2000-07-26 |
2005-09-06 |
Taro Pharmaceuticals Industries Limited |
Non-sedating barbituric acid derivatives
|
|
US7683071B2
(en)
*
|
2000-07-26 |
2010-03-23 |
Taro Pharmaceuticals Industries Ltd. |
Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
|
|
US6756379B2
(en)
*
|
2001-07-26 |
2004-06-29 |
Taro Pharmaceutical Industries Ltd. |
Non-sedating barbiturate compounds as neuroprotective agents
|
|
CN1291720C
(zh)
|
2002-01-30 |
2006-12-27 |
塔罗制药工业有限公司 |
非镇静性巴比土酸衍生物
|
|
AR042444A1
(es)
|
2002-12-11 |
2005-06-22 |
Taro Pharmaceuticals Ireland L |
Metodo para el tratamiento de desordenes del movimiento mediante la utilizacion de acido barbiturico
|
|
CA2572797A1
(en)
*
|
2004-07-02 |
2006-01-12 |
Daniella Gutman |
A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
|
|
EP1625848A1
(en)
|
2004-08-10 |
2006-02-15 |
Taro Pharmaceuticals North America, Inc. |
Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid
|
|
WO2008066704A2
(en)
*
|
2006-11-14 |
2008-06-05 |
Taro Pharmaceuticals North America, Inc. |
Method of improving bioavailability for non-sedating barbiturates
|